Our group reported that Glrx KO mice develop hyperlipidemia, non-alcoholic fatty liver disease [17], and a cardiometabolic phenotype leading to diastolic dysfunction when fed a high fat diet (Osaki, et al. in prep). The gene discussed is GLRX; the disease is hyperlipidemia.